Oncolytics Biotech: Publication Shows Pelareorep Converts ‘Cold’ Liver Tumors to Immune—Active, Supporting its Backbone Immunotherapy Role

Oncolytics Biotech announced published data showing pelareorep converts immunologically inactive liver tumors into an immune—active state that may enable immunotherapy.Key Highlights:Original SEC Filing: ONCOLYTICS BIOTECH INC [ ONCY ] - 8-K - Sep. 29, 2026This is an AI-powered summary. It may cont…